Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms

Heart failure is the leading cause of death worldwide. Compound Danshen Dripping Pill (CDDP) or CDDP combined with simvastatin has been widely used to treat patients with myocardial infarction and other cardiovascular diseases in China. However, the effect of CDDP on hypercholesterolemia/atheroscler...

Full description

Bibliographic Details
Main Authors:	Yanfang Yang, Ke Feng, Liying Yuan, Yuxin Liu, Mengying Zhang, Kaimin Guo, Zequn Yin, Wenjia Wang, Shuiping Zhou, He Sun, Kaijing Yan, Xijun Yan, Xuerui Wang, Yajun Duan, Yunhui Hu, Jihong Han
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Compound danshen dripping pill Heart failure Hypercholesterolemia Atherosclerosis Simvastatin ApoE–/–LDLR–/– mice
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383522004798

Similar Items

Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
by: Le Liu, et al.
Published: (2022-10-01)

Compound Danshen Dripping Pills pretreatment protects the heart from ischemia/reperfusion injury by enhancing autophagic flux
by: Haiqiong Liu, et al.
Published: (2023-09-01)

Compound danshen dripping pills vs. nitrates for stable angina pectoris: a systematic review and meta-analysis
by: Mengying Zhang, et al.
Published: (2023-05-01)

Preventive effect and mechanism of compound Danshen dripping pills on contrast-induced nephropathy after percutaneous coronary interventional
by: Han Fu, et al.
Published: (2023-12-01)

Efficacy of INtensive Treatment vs. Standard Treatment of COmpound DanshEn Dripping Pills in Refractory Angina Patients With Incomplete Revascularization (INCODER Study): Study Protocol for a Multicenter, Double-Blind, Randomized Controlled, Superiority Trial
by: Zexuan Wu, et al.
Published: (2022-04-01)

Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
by: Minji Wi, et al.
Published: (2023-09-01)

Effect of adjuvant therapy with compound danshen drip pill on inflammatory factors and cardiac function after percutaneous coronary intervention for acute myocardial infarction: a systematic review and meta-analysis
by: Genhao Fan, et al.
Published: (2024-04-01)

The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation
by: Chunxiao Lv, et al.
Published: (2017-11-01)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023-05-01)

Recommendations on the Clinical Use of Compound Danshen Dripping Pills
by: Writing Group of Recommendations of Expert Panel from Chinese Geriatrics Society on the Clinical Use of Compound Danshen Dripping Pills
Published: (2017-01-01)

Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
by: Qian Zhang, et al.
Published: (2018-10-01)

Clinical observation of Zhengyuanyunsheng dripping pills for the treatment of non-proliferative diabetic macular edema
by: Xiao-Kang Guan, et al.
Published: (2013-10-01)

The Effects of Aspirin With Combined Compound Danshen Dropping Pills on Hemorheology and Blood Lipids in Middle-Aged and Elderly Patients With CHD: A Systematic Review and Meta-Analysis
by: Zhi Liu, et al.
Published: (2021-06-01)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
by: Ma S, et al.
Published: (2019-08-01)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
by: Lyu Nan, et al.
Published: (2021-10-01)

Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
by: Praseetha Kizhakkedath, et al.
Published: (2019-11-01)

LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
by: Ziye Chen, et al.
Published: (2021-09-01)

Efficacy observation of danshen injection iontophoresis treatment for vitreous hemorrhage
by: Jing Hao, et al.
Published: (2013-11-01)

Review of Danshen: From its metabolism to possible mechanisms of its biological activities
by: B. Mahalakshmi, et al.
Published: (2021-10-01)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
by: Muhammad Idrees, et al.
Published: (2018-07-01)

Allicin and Capsaicin Ameliorated Hypercholesterolemia by Upregulating LDLR and Downregulating PCSK9 Expression in HepG2 Cells
by: Nantiya Nawaka, et al.
Published: (2022-11-01)

Chemical Analysis of the Herbal Medicine Salviae miltiorrhizae Radix et Rhizoma (Danshen)
by: Hanqing Pang, et al.
Published: (2016-01-01)

An Integrative Pharmacology-Based Pattern to Uncover the Pharmacological Mechanism of Ginsenoside H Dripping Pills in the Treatment of Depression
by: Libin Zhao, et al.
Published: (2021-02-01)

Synergistic Effects of Danshen (Salvia Miltiorrhizae Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) Combination in Angiogenesis Behavior in EAhy 926 Cells
by: Xian Zhou, et al.
Published: (2017-11-01)

LDLR and ApoB are Major Genetic Causes of Autosomal Dominant Hypercholesterolemia in a Taiwanese Population
by: Kai-Chien Yang, et al.
Published: (2007-10-01)

Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
by: Xian Lv, et al.
Published: (2023-10-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells
by: Cheng-Yu Yang, et al.
Published: (2017-12-01)

Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice
by: Guoran Ruan, et al.
Published: (2018-04-01)

Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred1
by: L. Haddad, et al.
Published: (1999-06-01)

Double Off-line Two-dimensional Liquid Chromatography for Separation and Identification of Compounds in Salvia Miltiorrhiza (Danshen)
by: Ji-xia Wang, et al.
Published: (2015-07-01)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
by: Mengxi Wang, et al.
Published: (2021-02-01)

Clinical effect of Danshen injection iontophoresis combined with Lumbrokinase in early retinal vein occlusion patients
by: Xi-Gang Zhang, et al.
Published: (2015-01-01)

Proangiogenesis effects of compound danshen dripping pills in zebrafish
by: Yang-Xi Hu, et al.
Published: (2022-04-01)

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
by: Takahito Doi, et al.
Published: (2021-02-01)

A Pair of New Antioxidant Phenolic Acid Stereoisomers Isolated from Danshen Injection (Lyophilized Powder)
by: Jing Liu, et al.
Published: (2014-02-01)

Real‐time droplet size analysis using laser micrometer as a process analytical technology tool for continuous dripping process
by: Xiaoping Wang, et al.
Published: (2022-09-01)

A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE‐1 insertion in LDLR
by: Yongjun Song, et al.
Published: (2024-03-01)

Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network
by: Dongxue Wu, et al.
Published: (2020-02-01)

Efficacy of Danshen injection iontophoresis in the treatment of retinal vein occlusion
by: Ya-Kun Li, et al.
Published: (2022-10-01)